News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
Most cancer drugs granted accelerated approval did not demonstrate benefit in overall survival – JAMA Oncology
Photo from JAMA Oncology/X
Apr 11, 2024, 12:58

Most cancer drugs granted accelerated approval did not demonstrate benefit in overall survival – JAMA Oncology

JAMA Oncology shared on X/Twitter:

“Most cancer drugs granted accelerated approval did not demonstrate benefit in overall survival or quality of life within 5 years of accelerated approval.”

Visit the article website.
Source: JAMA Oncology/X

approval cancer cancer drugs JAMA Oncology OncoDaily Oncology
Blog
Jul 31, 2024, 06:06
Michael Frühwald's session on Extracranial Rhabdoid Tumors at SIOP Congress
Insight
Jul 31, 2024, 06:01
New York Cancer and Blood Specialists become ASCO Certified
Blog
Jul 31, 2024, 05:56
Eric and Wendy Schmidt AI in Science Fellowships are now open for applications - ICR
Blog
Jul 31, 2024, 05:32
Yeliz Yilmaz: Joining the EACR community was one of the best decisions in my career
Blog
Jul 31, 2024, 04:19
ECO announces the co-chairs of its Health Systems and Quality Cancer Care Network
Career
Jul 31, 2024, 04:14
The Max Foundation is seeking Senior Director of Development
Blog
Jul 31, 2024, 04:06
Samantha Siegel: There is value in just being there with people, that is medicine too
Blog
Jul 31, 2024, 03:59
Survey on neuroprotection practices for brain metastases by ESTRO CNS Focus Group
Blog
Jul 31, 2024, 03:54
What is Immunotherapy? - Agenus
Blog
Jul 31, 2024, 03:46
ECO Community 365 Roundtable: HTA Regulation
Blog
Jul 31, 2024, 03:40
Applications for the FDA-AACR Oncology Educational Fellowship are still open
Blog
Jul 31, 2024, 03:31
The urgent need for stronger EDI-focused policies and actions - Youth Cancer Europe